Higher-dose semaglutide or tirzepatide use , doses under 2mg weekly are rarely implicated, while higher obesity-treatment doses show a clearer dose-dependent relationship
If you are investigating triple-receptor pharmacology in metabolic, hepatic, or cardiometabolic models, retatrutide is the lead compound and the one Velora supplies as GLP-3 RT
Nausea, vomiting, and diarrhea can make you take in less fluid and lose more than usual
Appeals require additional documentation, often including specialist referrals (endocrinologist, bariatric physician), more detailed medical history, and sometimes peer-reviewed studies supporting medication use for your specific case
Preliminary searches have been completed (Oct 2024 and Jan 2025), with follow-up searches ongoing
How Microdosing GLP-1s Got Popular Despite these cons, microdosing GLP-1s seems to be everywhere on social media